These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4400152)

  • 1. [Treatment of essential arterial hypertension with a thiazide-spironolactone-reserpine derivative combination].
    Klepping C; Villand J
    J Med Lyon; 1971 Sep; 52(213):1139-41. PubMed ID: 4400152
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of a thiazic-antialdosterone-rescinnamine association in the treatment of arterial hypertension (42 cases)].
    Delahaye JP; Touboul P; Delaye J; Gonin A
    Lyon Med; 1970 Nov; 224(37):627-34. PubMed ID: 4394975
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of a diuretic agent with thiazic-antialdosterone and rescinamine in the treatment of arterial hypertension].
    Warembourg H; Lekieffre J; Ducloux G; Dupuis B
    Lille Med; 1970; 15():Suppl 5:1014+. PubMed ID: 4394714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of baronorm in the treatment of hypertension].
    Ben-Ismail M; Girardet JP
    Tunis Med; 1972; 50(2):145-8. PubMed ID: 4661605
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of arterial hypertension with Sali-Raufunction].
    Schütz E
    Ther Ggw; 1979 Sep; 118(9):1386-91. PubMed ID: 494134
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new hypotensive agent: FH109C. Apropos of 32 cases].
    Gilgenkrantz JM; Hua G; Weiller M; Polu JM; Mayer G
    Presse Med (1893); 1971 Jan; 79(4):151-2. PubMed ID: 4395623
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of essential hypertension with baronorm. Results of an experimentation on 35 cases].
    Menechet F; Fontanille P
    Bord Med; 1972 Apr; 5(7):851-4. PubMed ID: 5055353
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of an antihypertensive combination].
    Leng-Lévy J; Aubertin J; Leng B; Mayeux A
    Bord Med; 1972 Jun; 5(12):1487-9. PubMed ID: 4651175
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hypertension with Detensitral. A therapeutic principle for general practice].
    Buchalik M
    Z Allgemeinmed; 1971 Oct; 47(30):1590-3. PubMed ID: 4399684
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of arterial hypertension with an original association of a salidiuretic, an anti-aldosterone and an alkaloid of Rauwolfia].
    Herne N; Marion J; Antiglio V; Treguier JY
    Mars Med; 1971; 108(4):325-9. PubMed ID: 5563029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of arterial hypertension. Clinico-therapeutical aspects of a new association: potassium cancreonate of altizide-rescinnamine].
    Restivo O; Sindoni G; Ballati S; Foti V
    Minerva Cardioangiol; 1973 Sep; 21(9):585-604. PubMed ID: 4147632
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical activity of a new hypotensive agent].
    Warembourg H; Dupuis B
    Lille Med; 1970; 15():Suppl 5:1011+. PubMed ID: 5480416
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension.
    Pinto JM
    East Afr Med J; 1981 Jan; 58(1):44-50. PubMed ID: 7011783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antialdosterones and arterial hypertension. Apropos of 32 hypertensive cases treated with an aldactone-derivative-thiazide combination].
    Delahaye JP; Lieux JM; Gonin A
    Lyon Med; 1966 Sep; 216(38):477-97. PubMed ID: 5981275
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advantage of the diuretic "thiazide-spironolactone" associati in the treatment of arterial hypertension].
    Lagrue G; Ménard J; Schlotterer P; Safar M
    Presse Med (1893); 1969 Dec; 77(56):2157-8. PubMed ID: 5374259
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our experience in the treatment of arterial hypertension with clonidine and thiazides].
    Stevens H; Medrano G; Zajarías S
    Arch Inst Cardiol Mex; 1972; 42(6):897-907. PubMed ID: 4567369
    [No Abstract]   [Full Text] [Related]  

  • 17. Spironolactone and hydroflumethiazide in the treatment of hypertension.
    Akbar FA; Boston PF; Chapman J; Pearce MY
    Br J Clin Pract; 1981 Sep; 35(9):317-21. PubMed ID: 7034762
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH; Larochelle P; Ogilvie RI
    Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of enduron-deserpidine].
    Warembourg H; Bertrand M
    Lille Med; 1967 Feb; 12(2):Suppl:120-2. PubMed ID: 5623380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detensitral--a new antihypertensive agent].
    Schaub K; Schaub E
    Z Allgemeinmed; 1970 Sep; 46(27):1350-3. PubMed ID: 4394366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.